Below is an educational, technical answer to a question many patients and clinicians ask. Extended wear over days to weeks is intended to increase the chance of capturing infrequent arrhythmias compared with very short recordings. As a medical device manufacturer, INVAMED develops technologies in this area; the information here is educational and not medical advice.
Background: Remote Cardiac Rhythm Monitoring for Arrhythmias
It is used to help detect and characterize arrhythmias such as atrial fibrillation (AFib) and ventricular tachycardia that may occur intermittently and be missed by a brief in-clinic test. Extended wear over days to weeks is intended to increase the chance of capturing infrequent arrhythmias compared with very short recordings. These systems support diagnosis and follow-up by a clinician, who interprets the recordings and decides on any next steps.
What is the difference between MCT and a Holter monitor?
A Holter typically records continuously for a short, fixed period and is analyzed after return, while mobile cardiac telemetry monitors over a longer window and can transmit data. MCT is aimed at capturing intermittent events that a brief Holter might miss. RhythmTrack supports typical wear periods of 7 to 14 days or more with secure cloud streaming, per INVAMED. Which is appropriate depends on symptom frequency and is decided by the clinician.
What This Means in Practice
AI-enhanced classification is intended to support clinician review, which remains the basis for interpretation and any decisions. The monitoring duration and device type are chosen to match how frequently a patient's symptoms or events are expected, as determined by the clinician. Connectivity and secure cloud streaming underpin remote review, and data-handling practices should meet applicable requirements.
Key Considerations
- Connectivity and secure cloud streaming underpin remote review, and data-handling practices should meet applicable requirements.
- Wear format options such as patch or belt affect comfort during extended monitoring and are selected per the clinical need.
- Descriptions of features and wear periods reflect INVAMED's product specifications rather than a diagnostic promise for any patient.
Frequently Asked Questions
Who decides which cardiac monitor is appropriate?
A qualified clinician selects the monitoring approach based on the clinical situation; this content is educational and not medical advice.
Does RhythmTrack diagnose arrhythmias by itself?
It is designed to record and help classify rhythm data to support clinical review; interpretation and any diagnosis remain with the reviewing clinician.
How does RhythmTrack transmit data?
RhythmTrack uses cellular or Wi-Fi connectivity with secure cloud streaming, and includes AI-enhanced arrhythmia classification and auto-report generation, per INVAMED.
About INVAMED
Device availability and regulatory status vary by country. Please contact INVAMED or your authorized local distributor for current regulatory information applicable to your region.
Clinical and Technical Context
How and when MCT is used for a given patient is determined by the ordering clinician based on the clinical question. RhythmTrack includes AI-enhanced arrhythmia classification and auto-report generation, according to INVAMED. RhythmTrack supports typical wear periods of 7 to 14 days or more, according to INVAMED. RhythmTrack is positioned to help detect arrhythmias such as atrial fibrillation as part of out-of-hospital monitoring. Extended wear over days to weeks is intended to increase the chance of capturing infrequent arrhythmias compared with very short recordings. AI-enhanced classification is intended to support clinician review, which remains the basis for interpretation and any decisions. Remote cardiac monitoring uses wearable or connected devices to record a patient's heart rhythm outside the hospital, sending the data for review. It is used to help detect and characterize arrhythmias such as atrial fibrillation (AFib) and ventricular tachycardia that may occur intermittently and be missed by a brief in-clinic test.
Related on INVAMED
- Digital Health & Remote Monitoring — product category
- Understanding Atrial Fibrillation Detection
- Understanding Regulatory and Platform Considerations
- Understanding Extended Wear Periods
Important Disclaimer
The information here is provided for educational purposes and to describe device technology; it is not a substitute for professional medical advice, diagnosis, or treatment. Only a licensed healthcare provider can determine whether a given procedure or device is appropriate for a specific patient. INVAMED products are restricted to use by qualified professionals following the official IFU. Regulatory clearance and labeling differ between regions, and not all products or indications are available in every market.
Reviewed by the INVAMED Medical Affairs team. Content is educational and technical in nature.